imatinib mesylate combined with hematopiotic stem cell transplantation for chronic myloid leukemia;

1、

the early efficacy of imatinib in the treatment of 54 cases of chronic myeloid leukemia

甲磺酸伊马替尼治疗慢性粒细胞白血病54例近期疗效观察

互联网摘选

2、

effects of imatinib mesylate in patients with chronic myeloid leukemia;

甲磺酸伊马替尼治疗慢性粒细胞白血病的循征评价更详细。

互联网摘选

3、

the advances in clinical study of imatinib mesilate

甲磺酸伊马替尼临床研究概况

互联网摘选

4、

imatinib breakthrough drug for chronic myeloid leukemia, imatinib

治疗慢性粒细胞白血病新药

互联网摘选

5、

clinical evaluation of imatinib mesylate in the treatment of blast-phrase chronic myeloid leukemia

甲磺酸伊马替尼治疗慢性粒细胞白血病急变期的疗效分析

互联网摘选

6、

attentive questions about the treatment of chronic myelogenous leukemia with imatinib mesylate

甲磺酸伊马替尼治疗慢性粒细胞白血病需注意的问题

互联网摘选

7、

clinical observation on the effects of low dosage imatinib to chronic myelogenous leukemia in blast crisis

小剂量伊马替尼治疗慢性髓细胞白血病急变期患者的临床疗效

互联网摘选

8、

mechanism and strategy against imatinib-resistant chronic myeloid leukemia

慢性粒细胞白血病伊马替尼耐药性的机制与对策

互联网摘选

9、

efficacy of imatinib mesylate in treatment of advanced gastrointestinal stromal tumors

甲磺酸伊马替尼治疗晚期胃肠道恶性间质瘤疗效的初步观察

互联网摘选

10、

nonmyleoablative allogeneic stem cell transplantation combined with imatinib in treatment of chronic myeloid leukemia: a clinical study

非清髓异基因造血干细胞移植联合伊马替尼治疗慢性粒细胞白血病的临床研究

互联网摘选

11、

analysis of abl tyrosine kinase point mutations in imatinib treated chronic myelogenous leukemia patients

慢性髓性白血病患者伊马替尼治疗后ABL激酶区点突变分析

互联网摘选

12、

efficacy and safety evaluation of imatinib in the treatment of patients with chronic granulocytic leukemia in accelerated phase

伊马替尼治疗慢性粒细胞白血病加速期疗效评价

互联网摘选

13、

resistance in the treatment for chronic myelogenous leukemia with imatinib and its management

伊马替尼治疗慢性粒细胞白血病的耐药与对策

互联网摘选

14、

clinical study of chinese gastrointestinal stromal tumors patients treated with imatinib mesylate

甲磺酸伊马替尼治疗国人胃肠间质瘤的临床研究

互联网摘选

15、

objective to study and improve the synthesis of imatinib mesylate.

目的研究和改进甲磺酸伊马替尼的合成工艺。

互联网摘选

16、

objective to study the treatment and its possible mechanism of imatinib-induced severe fluid retention in chromic myeloid leukemia(cml).

目的探讨应用伊马替尼（格列卫）治疗慢性粒细胞白血病发生严重水潴留的处理及其可能的发生机制。

互联网摘选

17、

but imatinib is known to cause heart problems in some people because it also switches off tyrosine kinases in the abl family.

但伊马替尼是众所周知的导致心脏问题，在一些人，因为它还要开关小康酪氨酸激酶在abl的家庭。

互联网摘选

18、

imatinib was re introduced in patients who had molecular relapse.

出现分子学复发的患者，再次应用伊马替尼。

互联网摘选

19、

imatinib is currently the most popular therapy for chronic myeloid leukemia (cml).

伊马替尼是目前治疗慢性髓细胞白血病的最普遍药物。

互联网摘选

20、

the next step, says jiang is finding a drug that blocks ahi-1, which could potentially be given in combination with imatinib in the future.

江表示，下一步是找一种阻滞AHI-1的药物，这种药物可能在将来与伊马替尼联用于治疗。

互联网摘选